Literature DB >> 16214451

Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction.

Wildon R Farwell1, Howard D Sesso, Julie E Buring, J Michael Gaziano.   

Abstract

Low-density lipoprotein (LDL) cholesterol is the primary lipid parameter targeted to prevent myocardial infarction. Alternatively, non-high-density lipoprotein (HDL) cholesterol includes LDL cholesterol and other atherogenic particles but does not require a fasting sample. Non-HDL cholesterol and LDL cholesterol as predictors of first nonfatal myocardial infarction were compared in 303 patients and 297 controls matched for age, gender, and community within the Boston Area Health Study. Patients were white men or women aged <76 years living in the Boston area, without a history of myocardial infarction or angina pectoris, in whom symptoms of confirmed myocardial infarction began during the 24 hours before admission. After multivariate adjustment for coronary risk factors in unmatched analyses, the corresponding odds ratios (ORs) of a first nonfatal myocardial infarction for non-HDL cholesterol in the second, third, and fourth quartiles were 1.83 (95% confidence interval [CI] 1.07 to 3.14), 2.07 (95% CI 1.23 to 3.49), and 2.33 (95% CI 1.39 to 3.90) (p trend <0.01). For LDL cholesterol, the ORs were 1.10 (95% CI 0.67 to 1.81), 0.87 (95% CI 0.52 to 1.46), and 1.45 (95% CI 0.90 to 2.35) (p trend = 0.16). Including HDL cholesterol in the model increased the ORs and strengthened the test for a trend for LDL cholesterol, whereas the ORs were decreased and the test for a trend was weakened for non-HDL cholesterol. In conclusion, given that non-HDL cholesterol accounts for LDL cholesterol plus other atherogenic particles but does not require a fasting sample, this study suggests that non-HDL cholesterol may be at least as useful as LDL cholesterol to initially screen patients for risk of a first nonfatal myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214451     DOI: 10.1016/j.amjcard.2005.06.044

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Non-HDL Cholesterol: A New Endpoint in Cardio-Metabolic Health Monitoring.

Authors:  Ross A Baker; Robert A Forbes
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  High-density lipoprotein and mortality before age 90 in male physicians.

Authors:  Catherine Rahilly-Tierney; Howard D Sesso; J Michael Gaziano; Luc Djoussé
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-04-03

3.  Increased non-HDL-C level linked with a rapid rate of renal function decline in HIV-infected patients.

Authors:  Masaki Hara; Naoki Yanagisawa; Akihito Ohta; Kumiko Momoki; Ken Tsuchiya; Kosaku Nitta; Minoru Ando
Journal:  Clin Exp Nephrol       Date:  2016-05-18       Impact factor: 2.801

4.  Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats.

Authors:  Jianzhao Huang; Nan Xiao; Yiying Sun; Shanshan Wu; Wenni Tian; Yujian Lai; Pan Li; Bing Du
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-31       Impact factor: 4.813

5.  Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine.

Authors:  John W Newcomer; Jonathan M Meyer; Ross A Baker; James M Eudicone; Andrei Pikalov; Estelle Vester-Blokland; Robert D McQuade; David T Crandall; William H Carson; Ronald N Marcus; Gilbert L'italien
Journal:  Schizophr Res       Date:  2008-10-29       Impact factor: 4.939

6.  Non-high-density lipoprotein cholesterol on the risks of stroke: a result from the Kailuan study.

Authors:  Jianwei Wu; Shengyun Chen; Yong Zhou; Chunxue Wang; Anxin Wang; Qian Zhang; Xiang Gao; Haitao Hu; Shouling Wu; Xingquan Zhao
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

7.  Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study.

Authors:  Chaoyang Li; Earl S Ford; James Tsai; Guixiang Zhao; Lina S Balluz; Samuel S Gidding
Journal:  Cardiovasc Diabetol       Date:  2011-05-23       Impact factor: 9.951

8.  The association between screen time and cardiometabolic risk in young children.

Authors:  Harunya Sivanesan; Leigh M Vanderloo; Charles D G Keown-Stoneman; Patricia C Parkin; Jonathon L Maguire; Catherine S Birken
Journal:  Int J Behav Nutr Phys Act       Date:  2020-04-29       Impact factor: 6.457

9.  Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction.

Authors:  Manoj Sigdel; Binod Kumar Yadav; Prajwal Gyawali; Prashant Regmi; Sushil Baral; Shyam Raj Regmi; Bharat Jha
Journal:  BMC Res Notes       Date:  2012-11-17

10.  Comparison of various lipid parameters in association of target organ damage: a cohort study.

Authors:  Chen Chi; Jiadela Teliewubai; Yu-Yan Lu; Xi-Min Fan; Shi-Kai Yu; Jing Xiong; Yi-Wu Zhou; Hong-Wei Ji; Yi Zhang; Ya-Wei Xu
Journal:  Lipids Health Dis       Date:  2018-08-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.